Affiliation: Long Island Jewish Medical Center
- Lithium treatment of acute mania in adolescents: a large open trialVivian Kafantaris
Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY, USA
J Am Acad Child Adolesc Psychiatry 42:1038-45. 2003....
- Lower orbital frontal white matter integrity in adolescents with bipolar I disorderVivian Kafantaris
Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System
J Am Acad Child Adolesc Psychiatry 48:79-86. 2009..To examine white matter microstructure, as assessed via diffusion tensor imaging (DTI), in adolescents with bipolar I disorder compared with control volunteers...
- Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation studyVivian Kafantaris
Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
J Am Acad Child Adolesc Psychiatry 43:984-93. 2004..There are no published placebo-controlled studies of any agent in the treatment of acute mania in children or adolescents. This is the first placebo-controlled study of lithium's efficacy in the treatment of acute mania in adolescents...
- Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysisTaro Kishi
The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
J Clin Psychiatry 73:e757-66. 2012..To assess the utility of antipsychotics for weight gain and improvement of illness-related psychopathology in patients with anorexia nervosa...
- Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorderDaniel J Coletti
Division of Psychiatry Research, North Shore LIJ Health System, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
J Child Adolesc Psychopharmacol 22:226-37. 2012..This report describes results from formative research that used focus groups to obtain parent input to guide development of a provider-delivered intervention to improve adherence to stimulants...
- Pharmacological treatment of bipolar disorder among children and adolescentsJoseph C Blader
Stony Brook State University of New York, NY, USA
Expert Rev Neurother 7:259-70. 2007..By summarizing current research and opinion on diagnostic issues and treatment approaches, this review aims to provide an update on a clinically important yet controversial topic...
- Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episodeChristoph U Correll
The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, NY Hofstra North Shore LIJ School of Medicine, Hempstead, NY The Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY
Bipolar Disord 16:478-92. 2014..The aim of the present study was to systematically evaluate the prodrome to mania in youth...
- A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosaVivian Kafantaris
Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, New York 11004, USA
J Child Adolesc Psychopharmacol 21:207-12. 2011....
- A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agentsEma Saito
Department of Psychiatry Research, The Zucker Hillside Hospital, Long Island Jewish Medical Center, New Hyde Park, NY, USA
J Child Adolesc Psychopharmacol 14:350-8. 2004..We hypothesized: (1) risperidone would be associated with hyperprolactinemia most frequently, and (2) postpubertal females may be at higher risk of prolactin elevation and associated adverse effects...
- Age-associated alterations in corpus callosum white matter integrity in bipolar disorder assessed using probabilistic tractographyNitin Toteja
SUNY Downstate Medical Center, Brooklyn, NY, USA
Bipolar Disord 17:381-91. 2015..The goal of this study was to identify possible deviations in the typical pattern of age-associated changes in white matter integrity in patients with bipolar disorder across the age range of 9-62 years...
- Development and reliability of the HAM-D/MADRS interview: an integrated depression symptom rating scaleRebecca W Iannuzzo
Center for Neuropsychiatric Outcome and Rehabilitation Research CENORR, The Zucker Hillside Hospital, Long Island Jewish Medical Center, 75 59 263rd Street, Ambulatory Care Pavilion, Room 2219, Glen Oaks, NY 11004, USA
Psychiatry Res 145:21-37. 2006..The HMI provides an easily administered, reliable method of rating depression severity which may improve consistency and validity of study findings...
- Can diabetes mellitus be induced by medication?Ema Saito
Division of Child and Adolescent Psychiatry, Schneider Children s Hospital, North Shore Long Island Jewish Health System, New Hyde Park, New York 11040, USA
J Child Adolesc Psychopharmacol 12:231-6. 2002..All were African American, obese, and had a family history of diabetes mellitus. We discuss each case and examine the possibility of psychotropic medication-induced diabetes mellitus in adolescents...
- Treatment of withdrawal dyskinesiaVivian Kafantaris
J Am Acad Child Adolesc Psychiatry 44:1102-3. 2005
- Lithium, minocycline, and pseudotumor cerebriJanardhana Jonnalagadda
J Am Acad Child Adolesc Psychiatry 44:209. 2005
- Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparisonSanjiv Kumra
Department of Child and Adolescent Psychiatry, University of Minnesota, Minneapolis, Minnesota 55454 1495, USA
Biol Psychiatry 63:524-9. 2008..The present study evaluated the effectiveness and safety of clozapine versus "high-dose" olanzapine in treatment-refractory adolescents with schizophrenia...
- Macrocytosis associated with divalproex treatmentRuth Tsivkin
Division of Child and Adolescent Psychiatry, The Zucker Hillside Hospital, New Hyde Park, New York 11040, USA
J Child Adolesc Psychopharmacol 15:1011-4. 2005....
- Patterns of adherence to treatment in adolescents with bipolar disorderDaniel J Coletti
St Mary s Healthcare System for Children, Department of Behavioral Health Services, Bayside, New York, USA
J Child Adolesc Psychopharmacol 15:913-7. 2005..Nonetheless, findings suggest vigilant monitoring of medication administration prior to assessing regimen effectiveness...